Alshafie Walaa, Pan Yingzhou Edward, Kreienkamp Hans-Jürgen, Stroh Thomas
Department of Neurology and Neurosurgery, McGill University, and the Montreal Neurological Institute, Montreal, QC, Canada.
Institute for Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Endocrine. 2020 Sep;69(3):655-669. doi: 10.1007/s12020-020-02329-x. Epub 2020 May 7.
Somatostatin (SOM) receptor subtype 2 (SSTR2) is the major receptor subtype mediating SOM effects throughout the neuraxis. We previously demonstrated that the non-selective agonist [D-Trp]-SOM induces intracellular sequestration of SSTR2, whereas this receptor is maintained at the cell surface after treatment with the SSTR2-selective agonist L-779,976 in cells co-expressing SSTR2 and SSTR5.
In this study, we knocked-out SSTR5 in AtT20 cells endogenously expressing both SSTR2 and SSTR5 and used immuno-labeling and confocal microscopy to investigate the effect of SSTR5 on regulation of SSTR2 trafficking. Our results indicate that unlike [D-Trp]-SOM-induced intracellular sequestration, L-779,976 stimulation results in the maintenance of SSTR2 at the cell surface regardless of whether SSTR5 is present or not. We then examined the trafficking pathways of SSTR2 upon stimulation by either agonist. We found that both [D-Trp]-SOM and L-779,976 induce SSTR2 internalization via transferrin-positive vesicles. However, SSTR2 internalized upon L-779,976 treatment undergoes rapid recycling to the plasma membrane, whereas receptors internalized by [D-Trp]-SOM recycle slowly after washout of the agonist. Furthermore, [D-Trp]-SOM stimulation induces degradation of a fraction of internalized SSTR2 whereas L-779,976-dependent, rapid SSTR2 recycling appears to protect internalized SSTR2 from degradation. In addition, Octreotide which has preferential SSTR2 affinity, induced differential effects on both SSTR2 trafficking and degradation.
Our results indicate that the biased agonistic property of L-779,976 protects against SSTR2 surface depletion by rapidly initiating SSTR2 recycling while SSTR5 does not regulate L-779-976-dependent SSTR2 trafficking.
生长抑素(SOM)受体亚型2(SSTR2)是介导SOM在整个神经轴突发挥作用的主要受体亚型。我们之前证明,非选择性激动剂[D-Trp]-SOM可诱导SSTR2在细胞内潴留,而在用SSTR2选择性激动剂L-779,976处理共表达SSTR2和SSTR5的细胞后,该受体维持在细胞表面。
在本研究中,我们敲除了内源性表达SSTR2和SSTR5的AtT20细胞中的SSTR5,并使用免疫标记和共聚焦显微镜研究SSTR5对SSTR2转运调控的影响。我们的结果表明,与[D-Trp]-SOM诱导的细胞内潴留不同,无论SSTR5是否存在,L-779,976刺激均可使SSTR2维持在细胞表面。然后,我们研究了两种激动剂刺激后SSTR2的转运途径。我们发现,[D-Trp]-SOM和L-779,976均可通过转铁蛋白阳性囊泡诱导SSTR2内化。然而,L-779,976处理后内化的SSTR2会迅速再循环至质膜,而[D-Trp]-SOM内化的受体在激动剂洗脱后再循环缓慢。此外,[D-Trp]-SOM刺激可诱导一部分内化的SSTR2降解,而L-779,976依赖性的SSTR2快速再循环似乎可保护内化的SSTR2不被降解。此外,对SSTR2具有优先亲和力的奥曲肽对SSTR2的转运和降解均产生不同影响。
我们的结果表明,L-779,976的偏向激动特性可通过快速启动SSTR2再循环来防止SSTR2从表面耗竭,而SSTR5不调节L-779,976依赖性的SSTR2转运。